ApoGlyx
Biotechnology Research
Lund, Skåne Län, Se
5 employees
- Employees
- 5
- Contacts
- 2
- Emails
- 2
ApoGlyx Overview
- Headquarters
- Lund, Skåne Län, Se
- Website
- apoglyx.com
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2015
- Funding
- 697.1K
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About ApoGlyx
Apoglyx is a pre-clinical stage biotech company with the aim to develop a small molecule therapy for sepsis, and further indications, based on inhibition of Aquaporin-9. Apoglyx was founded based on research from Aarhus University (DK), Aalborg University (DK), and Lund University (S).
ApoGlyx Contact Details
- People in AeroLeads
- 3
- With contact data
- 2
- Email contacts
- 2
- 66.7% coverage
ApoGlyx Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Filippo Perego | Doctoral Researcher at Apoglyx Ab |
View
|
|
| Preben Bruun-Nyzell | Chief Executive Officer at 2a Pharma | Greater Malmö Metropolitan Area, Sweden |
Email
|
| Helen Pettersson | Investment Manager På Almi Invest Syd | Sweden |
Email
|
Employees by Management Level
Executive
1 profile
Manager
1 profile
Individual contributor
1 profile
Compare Similar Companies to ApoGlyx
ALK
Pharmaceutical Manufacturing
Bavarian Nordic
Pharmaceutical Manufacturing
Bactolife
Biotechnology Research
Tetra Pharm Technologies
Biotechnology
AGB-Pharma AB
Pharmaceutical Manufacturing
EvodiaBio
Biotechnology Research
2A Pharma
Pharmaceutical Manufacturing
2N Pharma
Biotechnology Research
Swedish Biomimetics 3000 μLOT Technology
Biotechnology Research
Proency
Mental Health Care